Fund Holdings — Sands Capital Alternatives, LLC

Total Portfolio Value:
$456.42M
Total Bought:
$5.82M
Total Sold:
$69.61M
Net Transaction:
-$63.80M
Notable People:
Sands Capital Management, Lp, Erin Elizabeth Soule
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Nu Holdings Ltd.CL A(NU)7,175,4347,175,4340$98.45M$114.88M25.17%+$16.43M
Klaviyo, Inc.COM SER A(KVYO)3,515,0653,515,0650$118.04M$97.33M21.33%-$20.70M
Beta Bionics, Inc.(BBNX)3,570,1133,570,1130$51.98M$70.94M15.54%+$18.96M
Coupang, Inc.CL A(CPNG)849,031795,006-54,025$25.44M$25.60M5.61%+$162.2K
DoorDash, Inc.CL A(DASH)381,20290,142-291,060$93.97M$24.52M5.37%-$69.45M
Samsara Inc.CL A(IOT)438,485598,914+160,429$17.44M$22.31M4.89%+$4.87M
Inhibikase Therapeutics, Inc.(IKT)10,950,00010,950,0000$21.35M$17.74M3.89%-$3.61M
Datadog, Inc.CL A(DDOG)118,707118,7070$15.95M$16.90M3.70%+$958.0K
Monday Com LtdSHS
SHS
58,33658,3360$18.35M$11.30M2.48%-$7.05M
Tarsus Pharmaceuticals, Inc.(TARS)170,000170,0000$6.89M$10.10M2.21%+$3.22M
CrowdStrike Holdings, Inc.CL A(CRWD)15,61515,6150$7.95M$7.66M1.68%-$295.6K
Snowflake Inc.(SNOW)27,00527,0050$6.04M$6.09M1.33%+$48.1K
Acumen Pharmaceuticals, Inc.(ABOS)3,417,0753,417,0750$3.96M$5.84M1.28%+$1.88M
Toast, Inc.CL A(TOST)156,604156,6040$6.94M$5.72M1.25%-$1.22M
10x Genomics, Inc.CL A(TXG)481,770481,7700$5.58M$5.63M1.23%+$53.0K
BioAge Labs, Inc.(BIOA)786,353786,3530$3.25M$4.62M1.01%+$1.38M
Acrivon Therapeutics Inc2,122,6052,122,6050$2.53M$3.84M0.84%+$1.32M
Taysha Gene Therapies, Inc.(TSHA)724,873724,8730$1.67M$2.37M0.52%+$695.9K
Candel Therapeutics, Inc.(CADL)405,837405,8370$2.05M$2.07M0.45%+$16.2K
Figma, Inc.CL A(FIG)018,286+18,286$0$948.5K0.21%+$948.5K
Page 1 of 1
Sands Capital Alternatives, LLC — 13F Holdings — Q3 2025 | TickerTrail